Literature DB >> 29395576

Reduced-HMGB1 suppresses poly(I:C)-induced inflammation in keratinocytes.

Hideki Mori1, Masamoto Murakami2, Teruko Tsuda1, Kenji Kameda3, Ryo Utsunomiya1, Kana Masuda1, Ken Shiraishi1, Xiuju Dai1, Mikiko Tohyama1, Hiroki Nakaoka1, Koji Sayama1.   

Abstract

BACKGROUND: High mobility group box 1 (HMGB1) is a nuclear protein that stabilizes DNA and facilitates gene transcription. Additionally, cell stress or death induces the release of HMGB1 outside the cell membrane, where HMGB1 functions as an alarmin, causing an inflammatory response in combination with other cytokines, damage-associated molecular patterns (DAMPs), and pathogen-associated molecular patterns (PAMPs).
OBJECTIVE: To evaluate the effect of reduced-HMGB1 (previously termed chemoattractive-HMGB1) on polyinosine-polycytidylic acid [poly(I:C)]-induced inflammation in normal human keratinocytes (NHKs).
METHODS: We focused on downstream components of the poly(I:C)-Toll-like receptor 3 (TLR3), retinoic acid-inducible gene-I (RIG-I), and melanoma differentiation-associated protein 5 (MDA5) pathways, including IκBα, nuclear factor (NF)-κB p65, mitogen-activated protein kinase (MAPK), and interferon regulatory factor 3 (IRF3), and assessed whether these pathways are involved in the suppression of poly(I:C)-induced inflammation in NHKs by HMGB1. An immunoprecipitation was performed to know whether HMGB1 could bind to poly(I:C), and immunofluorescence staining and flow cytometric analysis were performed to check whether reduced-HMGB interferes with cellular uptake of poly(I:C) translocation (possibly by endocytosis).
RESULTS: Application of exogenous HMGB1 before, but not after, exerted a suppressive effect on poly(I:C)-induced inflammation in NHKs. In addition, reduced-HMGB1, but not disulfide-HMGB1, exerted a suppressive effect on poly(I:C)-induced inflammation in NHKs, suggesting the importance of the redox status of exogenous HMGB1. Pre-treatment with reduced-HMGB1 inhibited the phosphorylation of IκBα, NF-κB p65, and IRF3 induced by poly(I:C) stimulation in NHKs; however, phosphorylation of p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) was unaffected. Disulfide-HMGB1 formed a complex with poly(I:C), as did reduced- and oxidized-HMGB1, albeit to a lesser extent. Immunofluorescence staining and flow cytometric analysis indicated that reduced-HMGB interferes with cellular uptake of poly(I:C) translocation (possibly by endocytosis).
CONCLUSION: These findings suggest that pre-treatment with reduced-HMGB1 ameliorates poly(I:C)-mediated inflammation in NHKs.
Copyright © 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HMGB1; Inflammation; Keratinocytes; Poly (I:C); Redox

Mesh:

Substances:

Year:  2018        PMID: 29395576     DOI: 10.1016/j.jdermsci.2018.01.007

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  4 in total

1.  Restoration of calcium-induced differentiation potential and tight junction formation in HaCaT keratinocytes by functional attenuation of overexpressed high mobility group box-1 protein.

Authors:  Fumika Tanaka; Minori Uda; Yuina Hirose; Yohei Hirai
Journal:  Cytotechnology       Date:  2020-01-08       Impact factor: 2.058

2.  Phenformin Down-Regulates c-Myc Expression to Suppress the Expression of Pro-Inflammatory Cytokines in Keratinocytes.

Authors:  Guanyi Liu; Dingyang Li; Liwei Zhang; Qiuping Xu; Dexuan Zhuang; Panpan Liu; Ling Hu; Huiting Deng; Jianfeng Sun; Shuangshuang Wang; Bin Zheng; Jing Guo; Xunwei Wu
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

Review 3.  Role of HMGB1 in Cutaneous Melanoma: State of the Art.

Authors:  Federica Li Pomi; Francesco Borgia; Paolo Custurone; Mario Vaccaro; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

4.  HMGB1 Recruits TET2/AID/TDG to Induce DNA Demethylation in STAT3 Promoter in CD4+ T Cells from aGVHD Patients.

Authors:  Xuejun Xu; Yan Chen; Enyi Liu; Bin Fu; Juan Hua; Xu Chen; Yajing Xu
Journal:  J Immunol Res       Date:  2020-09-24       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.